Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer’s disease
Cholinesterase inhibitors (ChE-Is) are among the main drugs approved for the treatment of Alzheimer’s disease (AD). Rivastigmine in the form of a transdermal patch is an alternative delivery method, and can give greater treatment compliance. Objectives: To conduct a preliminary assessment of the neu...
Sparad:
| I publikationen: | Dementia & Neuropsychologia |
|---|---|
| Huvudupphov: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Associação Neurologia Cognitiva e do Comportamento
2011
|
| Ämnen: | |
| Länkar: | https://www.redalyc.org/articulo.oa?id=339529033012 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|